Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Premarket Review Pilot Aimed At Harmonization Ready For Launch At FDA

This article was originally published in The Gray Sheet

Executive Summary

Publication of a final guidance on harmonized premarket reviews clears the way for the U.S. component of an international pilot program

You may also be interested in...



Device Harmonization Hurdles On Horizon, CDRH Director Feigal Tells RAPS

Global harmonization efforts are making device product launches in different countries more difficult in the short term, according to CDRH Director David Feigal

Device Harmonization Hurdles On Horizon, CDRH Director Feigal Tells RAPS

Global harmonization efforts are making device product launches in different countries more difficult in the short term, according to CDRH Director David Feigal

First Concurrent U.S.-Japan STED Submission Is Under Way; FDA Pushes Pilot

The U.S. and Japan have agreed to evaluate the first summary technical document (STED) submitted simultaneously in the two countries

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018638

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel